1. Home
  2. IOVA vs LGIH Comparison

IOVA vs LGIH Comparison

Compare IOVA & LGIH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Iovance Biotherapeutics Inc.

IOVA

Iovance Biotherapeutics Inc.

HOLD

Current Price

$2.39

Market Cap

968.6M

Sector

Health Care

ML Signal

HOLD

Logo LGI Homes Inc.

LGIH

LGI Homes Inc.

HOLD

Current Price

$53.66

Market Cap

1.0B

ML Signal

HOLD

Company Overview

Basic Information
Metric
IOVA
LGIH
Founded
2007
2003
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Homebuilding
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
968.6M
1.0B
IPO Year
N/A
2013

Fundamental Metrics

Financial Performance
Metric
IOVA
LGIH
Price
$2.39
$53.66
Analyst Decision
Buy
Hold
Analyst Count
12
6
Target Price
$10.45
$75.90
AVG Volume (30 Days)
12.6M
441.3K
Earning Date
02-26-2026
02-17-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
4.53
Revenue
$250,425,000.00
$1,788,933,000.00
Revenue This Year
$60.71
N/A
Revenue Next Year
$59.52
$18.60
P/E Ratio
N/A
$11.86
Revenue Growth
175.62
N/A
52 Week Low
$1.64
$39.70
52 Week High
$6.50
$97.25

Technical Indicators

Market Signals
Indicator
IOVA
LGIH
Relative Strength Index (RSI) 45.56 67.53
Support Level $2.29 $41.97
Resistance Level $2.80 $53.99
Average True Range (ATR) 0.18 2.53
MACD -0.05 1.37
Stochastic Oscillator 13.57 86.59

Price Performance

Historical Comparison
IOVA
LGIH

About IOVA Iovance Biotherapeutics Inc.

Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company, pioneering a transformational approach to treating cancer by harnessing the human immune system's ability to recognize and destroy diverse cancer cells using therapies personalized for each patient. The company is preparing for potential U.S. regulatory approvals and commercialization of the first autologous T-cell therapy to address a solid tumor cancer. its objective is to be the leader in innovating, developing, and delivering tumor-infiltrating lymphocyte, or TIL, therapies for patients with solid tumor cancers.

About LGIH LGI Homes Inc.

LGI Homes Inc is engaged in the design, construction, and sale of new homes in markets. The company current product offerings include entry-level homes, including both detached homes and townhomes, and move-up homes sold, which are sold under LGI Homes brand, and luxury series homes, which are sold under the Terrata Homes brand. It offers a set number of floor plans in each community with features that include upgrades, such as granite countertops, appliances, and ceramic tile flooring. The company have seven operating segments ( West, Northwest, Central, Midwest, Florida, Southeast and Mid-Atlantic) that it aggregates into five qualifying reportable segment. Majority of the revenue is generated from Central division segment.

Share on Social Networks: